Ben Yong
SEC Form 4 insider trading activity
Ben Yong has filed 5 SEC Form 4 filings (5 transaction rows) across 2 companies, including CRBP, BBOT, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: Sep 15, 2026.
On the most recent filing, Ben Yong is listed as Director at Corbus Pharmaceuticals Holdings, Inc. Inside the rolling window, Ben Yong reported no open-market purchases and 1 open-market sale totaling $16K in CRBP.
Companies traded
Other insiders at CRBP
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$16K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Ben Yong made?
Ben Yong has filed 5 SEC Form 4 filings (5 transaction rows) across 2 companies, including CRBP, BBOT since 2026.
Which companies does Ben Yong trade?
Ben Yong has filed SEC Form 4 disclosures for 2 companies, including CRBP, BBOT.
When was Ben Yong's most recent SEC Form 4 filing?
Ben Yong's most recent SEC Form 4 filing on Tracefour is dated Sep 15, 2026.
What is Ben Yong's total buy and sell value in the current window?
Inside the rolling retention window, Ben Yong bought $0 and sold $16K based on SEC Form 4 filings.
What was Ben Yong's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 2,000 CRBP shares on 2026-09-14, worth $16K, per SEC Form 4 filings.